IP Verse

Methods For Detecting Symmetrical Demethylarginine

Patent No. EP2313364 (titled "Methods For Detecting Symmetrical Demethylarginine") was filed by Idexx Laboratories on Jul 30, 2009. The application was issued on Sep 2, 2020.

Patent Summary

A method for detecting symmetrical dimethylarginine (SDMA) in biological samples using anti-SDMA antibodies with minimal cross-reactivity to ADMA, arginine, and monomethylarginine. The antibodies are generated using SDMA analogs conjugated to carrier proteins, and are used in immunoassays to quantify SDMA levels in samples. The method enables the detection of SDMA as a biomarker for renal function, cardiovascular disease, and systemic lupus erythematosus.

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ZOETIS SERVICESJun 2, 2021DORRIES
ZOETIS SERVICESJun 2, 2021DORRIES, HANS ULRICH , DF-MP DORRIES FRANK-MOLNIA & POHLMAN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2313364

IDEXX LABORATORIES
Application Number
EP09790996A
Filing Date
Jul 30, 2009
Status
Granted And Under Opposition
Jul 31, 2020
Publication Date
Sep 2, 2020
External Links
Slate, Register , Google Patents